Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EDS-2022-01: Safety and Performance of the OTTAVA™ Robotic System: A Prospective, Multi-Center Evaluation (FORTE)

NCT06709261 is registered in ClinicalTrials.gov with Auris Health, Inc. as lead sponsor.

NCT NCT06709261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06709261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EDS-2022-01: Safety and Performance of the OTTAVA™ Robotic System: A Prospective, Multi-Center Evaluation (FORTE)
Lead sponsor
Auris Health, Inc.
Phase
Not applicable
Overall status
Completed
Start date
February 5, 2025
Completion date
October 20, 2025
Enrollment
32 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

obesity